Publication | Closed Access

Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non–insulin dependent diabetes mellitus

Percutaneous Coronary InterventionNon–insulin DependentCardiovascular DiseaseDiabetesCoronary Stent ImplantationVascular SurgeryPathologyVascular BiologyNeointimal Tissue ProliferationBiomedical EngineeringMicrovascular DysfunctionMedicineCardiologyCoronary Artery Disease